Conversely, mTORC2, which is rapamycin‐resistant and less influenced by nutrient status, primarily regulates cancer cell growth and proliferation and is key in AKT activation at Ser473.12, 15, 16, 17. This evidence concerns the gene AKT1 and cancer.